Hepatitis B and C

Luis Rodrigo

ISBN 10: 1789239478 / ISBN 13: 9781789239478

Verlag: Intechopen Apr 2020, 2020

Beschreibung

Neuware -This book on Hepatitis B and C contains very useful and recent information about the general characteristics of these common types of chronic liver infections. Referred to as Hepatitis B, there are three chapters describing the main epidemiological, clinical, therapeutic, and prognosis aspects. The molecular variants for HBsAg, its genotyping, and their clinical implications are fully analyzed. The implications of coinfection Hepatitis B and C in HIV patients and their treatment are described. In relation to Hepatitis C, there are three chapters describing the general characteristics of this chronic viral infection. The challenges and strategies for access to treatment of Hepatitis C in Latin America are fully covered and these can be applied in other countries with similar epidemiological and financial problems for access to treatment on a large scale. The role of direct-acting antivirals (DAA) in the treatment of chronic Hepatitis C infection with liver cirrhosis is clearly documented.Books on Demand GmbH, Überseering 33, 22297 Hamburg 112 pp. Englisch.

Bestandsnummer des Verkäufers 9781789239478

Bibliografische Details

• Titel: Hepatitis B and C
• Verlag: Intechopen Apr 2020
• Erscheinungsjahr: 2020
• Sprache: Englisch
• ISBN-10: 1789239478
• ISBN-13: 9781789239478
• Einband: Buch
• Zustand: Neu

Über diesen Titel

Inhaltsangabe

This book on Hepatitis B and C contains very useful and recent information about the general characteristics of these common types of chronic liver infections. Referred to as Hepatitis B, there are three chapters describing the main epidemiological, clinical, therapeutic, and prognosis aspects. The molecular variants for HBsAg, its genotyping, and their clinical implications are fully analyzed. The implications of coinfection Hepatitis B and C in HIV patients and their treatment are described. In relation to Hepatitis C, there are three chapters describing the general characteristics of this chronic viral infection. The challenges and strategies for access to treatment of Hepatitis C in Latin America are fully covered and these can be applied in other countries with similar epidemiological and financial problems for access to treatment on a large scale. The role of direct-acting antivirals (DAA) in the treatment of chronic Hepatitis C infection with liver cirrhosis is clearly documented.